NCT03878524 2024-03-04
Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
OHSU Knight Cancer Institute
Phase 1 Terminated
OHSU Knight Cancer Institute
Bristol-Myers Squibb
M.D. Anderson Cancer Center
University of Chicago
Northwestern University
M.D. Anderson Cancer Center
St. Petersburg State Pavlov Medical University